Acquired aplastic anaemia: a PNH-like disease?

Area of Science:

• Hematology
• Immunology
• Cell Biology

Background:

• Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by complement-sensitive hematopoietic stem cells.
• Aplastic anemia involves bone marrow failure, but the underlying cellular defects are not fully understood.

Purpose of the Study:

• To investigate the role of serum and complement in hematopoietic stem cell dysfunction in aplastic anemia.
• To determine if aplastic anemia patients share complement sensitivity with PNH patients.

Main Methods:

• Bone marrow cells from aplastic anemia and PNH patients were incubated with autologous serum.
• Colony formation assays for granulocyte-macrophage colony-forming cells (GM-CFC) and burst-forming unit-erythroid (BFU-E) were performed.
• Complement pathways were selectively inactivated using heat, EDTA, and Mg2+ EGTA to assess serum inhibitory effects.

Main Results:

• Fresh autologous serum significantly reduced colony formation (approx. 50%) by GM-CFC and BFU-E in aplastic anemia patients.
• This inhibitory effect was abrogated by heat or EDTA inactivation, indicating complement involvement.
• Selective inactivation of the classical complement pathway reduced inhibition by 50%, implicating this pathway.

Conclusions:

• Hematopoietic cells in aplastic anemia exhibit a PNH-like complement sensitivity at a primitive level.
• This finding suggests a potential shared pathogenic mechanism between aplastic anemia and PNH.
• The results highlight the importance of complement regulation in maintaining normal hematopoiesis.